CircPVT1 promotes ER‐positive breast tumorigenesis and drug resistance by targeting ESR1 and MAVS

The molecular mechanisms underlying estrogen receptor (ER)‐positive breast carcinogenesis and endocrine therapy resistance remain incompletely understood. Here, we report that circPVT1, a circular RNA generated from the lncRNA PVT1, is highly expressed in ERα‐positive breast cancer cell lines and tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Jia, Wang, Lei, Hu, Guo‐sheng, Zhang, Yue‐ying, Du, Jiao, Ding, Jian‐cheng, Ji, Xiang, Shen, Hai‐feng, Huang, Hai‐hua, Ye, Feng, Liu, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183818/
https://www.ncbi.nlm.nih.gov/pubmed/37009655
http://dx.doi.org/10.15252/embj.2022112408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183818/
https://www.ncbi.nlm.nih.gov/pubmed/37009655
http://dx.doi.org/10.15252/embj.2022112408

Ejemplares similares